Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4Breast 4Genitourinary 3Thoracic 2Sarcoma 2Lymphoid 2Gynecologic 2Plasma cell 1Other hematologic neoplasm 1NET 1Myeloid 1Head & Neck 1Endocrine 1Dermatologic 1Classical hematology 1CNS 1

Conditions

Thyroid Cancer, Papillary 1Sarcoma 1Salivary Gland Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neuroendocrine Tumors 1Melanoma 1Lymphoma, Large-Cell, Anaplastic 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Fluorodeoxyglucose F18 3Magnetic Resonance Spectroscopy 2Cyclophosphamide 2tivozanib 1romidepsin 1pembrolizumab 1gadoteridol 1gadoterate meglumine 1gadolinium ethoxybenzyl DTPA 1gadodiamide 1gadobutrol 1gadobenic acid 1fludarabine phosphate 1fludarabine 1entrectinib 1atezolizumab 1alectinib 1aldesleukin 1Specimen Handling 1Quality of Life 1Patient Reported Outcome Measures 1Neuropsychological Tests 1Molecular Diagnostic Techniques 1Lactones 1Interleukin-13 1Immunotherapy 1FAPI-46 1Drug Therapy 1Depsipeptides 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × entrectinib × NET × Clear all
NCT02568267 2026-05-27

STARTRK-2

Hoffmann-La Roche

Phase 2 Active not recruiting
534 enrolled 1 FDA
BreastCNSDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidNETSarcomaThoracic

Thyroid Cancer, Papillary, Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Colorectal Neoplasms, Lymphoma, Large-Cell, Anaplastic, Cholangiocarcinoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡